我要投票 天中依脉在医疗保健行业中的票数:27
· 外 推 电 报 ·
2024-11-24 11:19:55 星期日

【天中依脉是哪个国家的品牌?】

天中依脉是什么牌子?公司简介: 天中依脉集团成立于2009年,现拥有三家全资子公司:天津市天中依脉科技开发有限公司、依脉人工智能医疗科技(天津)有限公司和汇汉依脉智能科技(上海)有限公司。公司坐落于天津滨海高新区华苑产业

公司简介:

天中依脉集团成立于2009年,现拥有三家全资子公司:天津市天中依脉科技开发有限公司、依脉人工智能医疗科技(天津)有限公司和汇汉依脉智能科技(上海)有限公司。公司坐落于天津滨海高新区华苑产业区,是我国专注于中医四诊客观化技术研究和中医诊疗设备的研发与制造的科技型国内知名高新企业之一。公司具有国内一流的中医诊疗仪器研发团队,完善的生产体系和检验设备,产品质量稳定可靠。公司的脉象仪,舌象仪等产品获得国家中医药管理局中医诊疗设备2011版第一批推荐品目。

天中依脉是较早专注于中医诊疗客观化的高新技术企业,核心技术脱胎于天津中医药大学、天津大学历届专家及从上世纪80年代开始的“中医客观化技术”研究。依脉人工智能医疗科技(天津)有限公司是天中依脉的全资子公司,致力于发展“中医云脑”智能化云中医服务,参与国家“一带一路”中医文化传播与技术推广,全面支持国家医联体建设、家庭医生签约服务等领域的中医药服务,践行健康中国战略。

 15625675637646365997938.png

2009年创立至今,天中依脉与国内三十余家高校及高级医疗机构建立了长期深入的科研合作关系,拥有200多项国家专利及软件著作等知识产权,产品服务于500余家医疗机构,成为中医智能行业的领航者。

公司荣誉:

●2009年,参与国家中医诊断仪器国际以及国家行业标准制定

●2009年,参与火星MARS500计划项目

●2011年,参与承担国家973项目

●2011年,舌象仪和脉象仪同时入选国家中医药管理局《中医诊疗设备推荐品目2011版第一批》

●2012年,参与国家自然基金项目

●2012年,参与国家十二五支撑项目

●2013年,获得中国科技部“科技型中小企业技术创新基金”

●2018年,天中依脉“智云中医”中医医联体管理、服务体系上市,并与全国多家中医机构建立合作关系。

公司愿景:

1、中医客观化诊疗技术,中医健康大数据和人工智能科技的国际领导品牌!

2、建立开放、共享、共赢的中医健康数据服务平台,打造中医健康产业生态群。

3、推动先进的中医科技和传统文化走向世界,服务全人类健康!

公司使命:

创新中医科技,传承中医文化,引领健康生活!

英文翻译:Company profile: Tianzhong Yimai group, founded in 2009, now has three wholly-owned subsidiaries: Tianjin Tianzhong Yimai Technology Development Co., Ltd., Yimai artificial intelligence medical technology (Tianjin) Co., Ltd. and Huihan Yimai Intelligent Technology (Shanghai) Co., Ltd. The company is located in Huayuan Industrial Zone, Binhai high tech Zone, Tianjin. It is one of the well-known high-tech enterprises in China, which focuses on the research and development and manufacturing of the four diagnosis and treatment objectification technology of traditional Chinese medicine and the diagnosis and treatment equipment of traditional Chinese medicine. The company has a domestic first-class R & D team of TCM diagnosis and treatment instruments, perfect production system and testing equipment, and stable and reliable product quality. The company's pulse instrument, tongue instrument and other products have won the first batch of recommended items of Chinese medicine diagnosis and treatment equipment 2011 edition of the State Administration of traditional Chinese medicine. Tianzhong Yimai is an early high-tech enterprise focusing on the objectification of TCM diagnosis and treatment. Its core technology was born from the experts of Tianjin University of traditional Chinese medicine, Tianjin University and the research on "objectification technology of TCM" since the 1980s. One belt, one road, China's Tianjin medical company (China) is a wholly-owned subsidiary of the Chinese medicine company. It is committed to the development of the "Yun Nao" intelligent Chinese medicine service, participating in the "one belt and one way" Chinese medicine culture dissemination and technology promotion, and fully supporting the traditional Chinese medicine service in the fields of national medical conjoined construction, family doctor's contract service and so on, and practicing the healthy China strategy. Since its establishment in 2009, Tianzhong Yimai has established a long-term and in-depth scientific research cooperation relationship with more than 30 universities and advanced medical institutions in China. It has more than 200 national patents and software works and other intellectual property rights. Its products serve more than 500 medical institutions and become a leader in the intelligent industry of traditional Chinese medicine. Honors of the company: ● in 2009, participated in the development of international and national industry standards for diagnostic instruments of traditional Chinese medicine ● in 2009, participated in Mars Mars 500 program project ● in 2011, participated in the national 973 project ● in 2011, tongue imager and pulse imager were selected into the first batch of recommended items of Chinese medical diagnosis and treatment equipment 2011 edition by the State Administration of traditional Chinese medicine ● in 2012, participated in the national natural fund project ● 201 2 years, participated in the national 12th Five Year Plan support project ● in 2013, won the "technology innovation fund for small and medium-sized enterprises of science and technology type" of the Ministry of science and technology of China ● in 2018, Tianzhong Yimai "Zhiyun TCM" TCM management and service system went public, and established cooperation with many TCM institutions across the country. Company vision: 1. Objective diagnosis and treatment technology of traditional Chinese medicine, international leading brand of health big data and artificial intelligence technology of traditional Chinese medicine! 2. Establish an open, shared and win-win TCM health data service platform, and build an ecosystem of TCM health industry. 3. Promote the advanced technology of traditional Chinese medicine and traditional culture to the world, and serve the health of all mankind! Mission of the company: innovate TCM technology, inherit TCM culture and lead healthy life!

本文链接: https://www.waitui.com/brand/93449407c.html 联系电话:022*****2300 立即查看

千城特选小程序码

7×24h 快讯

十月末全国普惠型小微企业贷款余额同比增14.98%

金融监管总局今天(24日)发布,截至10月末,全国普惠型小微企业贷款余额同比增长14.98%,贷款利率持续下降。数据显示,10月末,全国普惠型小微企业贷款余额32.45万亿元,同比增长14.98%,较各项贷款增速高7.47个百分点。其中,普惠型小微企业信用贷款余额同比增长30.56%,继续保持高速增长。(央视新闻)

2小时前

光大证券:AI眼镜有望迎来破圈时刻

光大证券研报认为,AI眼镜有望迎来破圈时刻。根据wellsenn XR数据及预测,2025年开始,AI智能眼镜将在传统眼镜销量保持稳定增长的大背景下快速向传统眼镜渗透;2029年,AI智能眼镜年销量有望达到5500万副;到2035年,AI智能眼镜销量有望达14亿副。AI眼镜、AI耳机、AI玩具、AI音箱等AI智能硬件加速渗透,AI新浪潮未来将提升海量IoT设备的边缘算力需求。

2小时前

国家统计局:11月中旬生猪(外三元)价格环比下降4.1%

国家统计局数据显示,据对全国流通领域9大类50种重要生产资料市场价格的监测显示,2024年11月中旬与11月上旬相比,15种产品价格上涨,35种下降。其中生猪(外三元)价格16.3元/千克,比上期价格跌0.7元,跌幅4.1%。(界面)

2小时前

联合国气候变化大会就新气候融资集体量化目标等议题达成一揽子成果

当地时间24日凌晨,在阿塞拜疆首都巴库举行的《联合国气候变化框架公约》第二十九次缔约方大会(COP29)就新的气候融资集体量化目标、《巴黎协定》第六条全球碳市场机制等议题达成一揽子成果。(央视新闻)

2小时前

英伟达正在尽快认证三星的AI内存芯片

英伟达CEO称,英伟达正在尽快认证三星的AI内存芯片,评估三星的8层堆叠和12层堆叠HBM3E内存。(财联社)

2小时前

本页详细列出关于卓誉科技的品牌信息,含品牌所属公司介绍,卓誉科技所处行业的品牌地位及优势。
咨询